Artículos por temáticas

Essential tremor: tips and tricks

Lapeña-Motilva J, Sánchez-Ferro Á, Méndez-Guerrero A, Rábano-Suárez P, Benito-León J.

Pract Neurol. 2025 Jul 14;25(4):313-322. doi: 10.1136/pn-2024-004094.

Quality of life measures in Parkinson's disease: a systematic literature review of patient-reported outcomes measures (PROMs) and their psychometric properties

de la Cuadra-Grande A, Rejas J, Casado MÁ, Monroy M, Ruiz M.

J Neurol. 2025 Aug 28;272(9):598. doi: 10.1007/s00415-025-13348-x.

Cognitive and Psychiatric Adverse Effects of Foslevodopa/Foscarbidopa in Patients with Parkinson's Disease

Brohée S, Roze E, Grabli D, Letrillart H, Mantisi L, Foucard C, Hainque E, Cormier F, Méneret A, Hauw F.

Mov Disord Clin Pract. 2025 Jul;12(7):1028-1030. doi: 10.1002/mdc3.70060. Epub 2025 Mar 28.

Appendectomy and risk of Parkinson's disease: a systematic review and meta-analysis

Chin HL, Tsang YS, Shi H.

Front Neurol. 2025 Jul 21;16:1619236. doi: 10.3389/fneur.2025.1619236. eCollection 2025.

Delayed orthostatic hypotension in Parkinson's disease and in the general ageing population

Calió B, Leys F, Matteucci G, Campese N, Rivasi G, Göbel G, Testa GD, Granata R, Dürr S, Ndayisaba JP, Radl K, Thurner-Rodriguez M, Seppi K, Poewe W, Kiechl S, Ungar A, Wenning G, Rafanelli M, Fanciul

Age Ageing. 2025 Jul 1;54(7):afaf187. doi: 10.1093/ageing/afaf187.

Parkinson's disease and the gut microbiota connection: unveiling dysbiosis and exploring therapeutic horizons

Yadav S, Raj RG.

Neuroscience. 2025 Aug 16;581:1-15. doi: 10.1016/j.neuroscience.2025.07.003. Epub 2025 Jul 2.

How leaky is the gut in Parkinson's disease?

Derkinderen P, Cossais F, Kulcsárová K, Škorvánek M, Sellier-Montaigne L, Coron E, Leclair-Visonneau L, Cerri S, Pellegrini C, Rolli-Derkinderen M.

EBioMedicine. 2025 Jul;117:105796. doi: 10.1016/j.ebiom.2025.105796. Epub 2025 Jun 3.

The role of endolysosomal progranulin and TMEM106B in neurodegenerative diseases

Takahashi H, Strittmatter SM.

Mol Neurodegener. 2025 Jul 26;20(1):86. doi: 10.1186/s13024-025-00873-6.

Imaging and neuromodulation in Parkinson's disease

Boutet A, Germann J, Fasano A.

Curr Opin Neurol. 2025 Aug 1;38(4):322-327. doi: 10.1097/WCO.0000000000001380. Epub 2025 May 21.

Education Programs for Patients With Parkinson's Disease Receiving Deep Brain Stimulation: A Scoping Review

Petralito M, Tedesco C, Pucciarelli G, Fanari F, Magon A, Terzoni S, Lusignani M, Caruso R.

West J Nurs Res. 2025 Aug;47(8):786-796. doi: 10.1177/01939459251341814. Epub 2025 May 24.

Retired dentists and Parkinson's disease

Willmot D.

Br Dent J. 2025 Jul;239(2):83-84. doi: 10.1038/s41415-025-9023-6. Epub 2025 Jul 25.

Multiple System Atrophy

Xie T.

Continuum (Minneap Minn). 2025 Aug;31(4):1000-1022. doi: 10.1212/cont.0000000000001598. Epub 2025 Aug 1.

Regulatory mechanisms and therapeutic potential of natural microglia inhibitors in Parkinson's disease

Jin TT, Shi RZ, Shi JW, Liu F, Liang YX.

J Asian Nat Prod Res. 2025 Aug 28:1-22. doi: 10.1080/10286020.2025.2544148. Online ahead of print.

Circadian clock dysfunction in Parkinson's disease: mechanisms, consequences, and therapeutic strategy

Yalçin M, Grande V, Outeiro TF, Relógio A.

NPJ Parkinsons Dis. 2025 Jul 14;11(1):213. doi: 10.1038/s41531-025-01009-9.

Synergistic pathways in Parkinson's disease: The promise of FGF21 and ACE2

Liu T, Li J, Yang Z, Wei J.

Ageing Res Rev. 2025 Aug;110:102804. doi: 10.1016/j.arr.2025.102804. Epub 2025 Jun 13.